This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Zadnik V, Primic Žakelj M, Lokar K, Jarm K, Ivanuš U, Žagar T. Cancer burden in Slovenia with the time trends analysis. Radiol Oncol 2017 22: 47-55. doi: 10.1515/raon-2017-0008.ZadnikVPrimicŽakelj MLokarKJarmKIvanušUŽagar TCancer burden in Slovenia with the time trends analysis201722475510.1515/raon-2017-0008Open DOISearch in Google Scholar
Bray F, Ferlay J, Soerjomataram I, Siegel RL, Torre LA, Jemal A. Global cancer statistics 2018: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin 2018; 68: 394-424. doi: 10.3322/caac.21492.BrayFFerlayJSoerjomataramISiegelRLTorreLAJemalA. Global cancer statistics2018GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries20186839442410.3322/caac.21492Open DOISearch in Google Scholar
Coleman MP, Alexe D, Albreht T, McKee M, eds. Responding to the challenge of cancer in Europe. Ljubljana: Institute of Public Health of the Republic of Slovenia; 2008.ColemanMPAlexeDAlbrehtTMcKeeMedsLjubljanaInstitute of Public Health of the Republic of Slovenia;2008Search in Google Scholar
Primic-Žakelj M, Zadnik V, Žagar T, Zakotnik B. [Survival of cancer patients, diagnosed in 1991–2005 in Slovenia.]. [Slovenian and English]. Ljubljana: Instititute of Occology Ljubljana; 2009.Primic-ŽakeljMZadnik VŽagarTZakotnikBLjubljanaInstititute of Occology Ljubljana;2009Search in Google Scholar
Zadnik V, Žagar T, Lokar K, Tomšič S, Duratović-Konjević A, Zakotnik B. [Survival of cancer patients, diagnosed in 1997–2016 in Slovenia.]. [Slovenian and English]. Ljubljana: Instititute of Oncology Ljubljana; 2021 in press.ZadnikVŽagarTLokarKTomšičSDuratović-KonjevićAZakotnikBLjubljanaInstititute of Oncology Ljubljana;2021in pressSearch in Google Scholar
CRRS. Cancer in Slovenia 2017. Ljubljana: Institute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia; 2020.CRRS2017LjubljanaInstitute of Oncology Ljubljana, Epidemiology and Cancer Registry, Cancer Registry of Republic of Slovenia;2020Search in Google Scholar
Zadnik V, Primic Žakelj M, Žagar T. Linkage to supplementary registration sources: key lessons learned in the last 30 years in Slovenia. In: Benider A, Zanetti R, Siesling S, Bray F, editors. The 38th Annual IACR Conference. Marrakech: IACR; 2016.ZadnikVPrimicŽakelj MŽagarTMarrakechIACR2016Search in Google Scholar
Pohar Perme M, Stare J, Esteve J. On estimation in relative survival. Biometrics 2012; 68: 113-20. doi: 10.1111/j.1541-0420.2011.01640.x.PoharPerme MStareJEsteveJOn estimation in relative survival2012681132010.1111/j.1541-0420.2011.01640.xOpen DOISearch in Google Scholar
Pohar Perme M, Esteve J, Rachet B. Analysing population-based cancer survival – settling the controversies. BMC Cancer 2016; 16: 933. doi: 10.1186/s12885-016-2967-9.PoharPerme MEsteveJRachetBAnalysing population-based cancer survival – settling the controversies20161693310.1186/s12885-016-2967-9Open DOISearch in Google Scholar
Zadnik V, Žagar T, Primic-Žakelj M. Cancer patients’ survival: standard calculation methods and some considerations regarding their interpretation. Zdrav Var 2016; 55: 134-41. doi: 10.1515/sjph-2016-0012.ZadnikVŽagarTPrimic-ŽakeljMCancer patients’ survival: standard calculation methods and some considerations regarding their interpretation2016551344110.1515/sjph-2016-0012Open DOISearch in Google Scholar
Pohar M, Stare J. Relative survival analysis in R. Computer Methods and Programs in Biomedicine 2006; 81: 272-8. doi: 10.1016/j.cmpb.2006.01.004.PoharMStareJRelative survival analysis in R200681272810.1016/j.cmpb.2006.01.004Open DOISearch in Google Scholar
Pompe-Kirn V, Zakotnik B, Volk N, Benulič T, Škrk J. Cancer patients survival in Slovenia: 1963-1990. Ljubljana: Institute of Oncology Ljubljana; 1995.Pompe-KirnVZakotnikBVolkNBenuličTŠkrkJLjubljanaInstitute of Oncology Ljubljana;1995Search in Google Scholar
Pompe-Kirn V, Zakotnik B, Zadnik V, Serša G. Cancer patients survival in Slovenia: 1983-1997. Ljubljana: Institute of Oncology Ljubljana; 2003.Pompe-KirnVZakotnikBZadnikVSeršaGLjubljanaInstitute of Oncology Ljubljana;2003Search in Google Scholar
Allemani C, Matsuda T, Di Carlo V, Harewood R, Matz M, Nikšić M, et al. Global surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries. Lancet 2018; 17: 1023-75. doi: 10.1016/S0140-6736(17)33326-3.AllemaniCMatsudaTDiCarlo VHarewoodRMatzMNikšićMet alGlobal surveillance of trends in cancer survival 2000-14 (CONCORD-3): analysis of individual records for 37 513 025 patients diagnosed with one of 18 cancers from 322 population-based registries in 71 countries20181710237510.1016/S0140-6736(17)33326-3Open DOISearch in Google Scholar
Hayes JH, Barrey MJ. Screening for prostate cancer with the prostate-specific antigen test: a review of current evidence. JAMA 2014; 311: 1143–9. doi: 10.1001/jama.2014.2085.HayesJHBarreyMJScreening for prostate cancer with the prostate-specific antigen test: a review of current evidence20143111143910.1001/jama.2014.208524643604Open DOISearch in Google Scholar
Jarm K, Hertl K, Krajc M, Šval C, Kutnar V, Kuri r-Borovčić M et al. [Ten years of the National breast cancer screening programme Dora.]. [Slovenian]. Onkologija 2020; 24: 12-22. doi: 10.25670/oi2020-008on.JarmKHertlKKrajcMŠvalCKutnarVKurir-Borovčić Met al[Ten years of the National breast cancer screening programme Dora.]. [Slovenian]202024122210.25670/oi2020-008onOpen DOISearch in Google Scholar
Zadnik V, Žagar T. SLORA: Slovenia and cancer. Epidemiology and Cancer Registry. Institute of Oncology Ljubljana. (cited 2020 Dec 26). Available at www.slora.siZadnikVŽagarTInstitute of Oncology Ljubljana(cited 2020 Dec 26). Available atwww.slora.siSearch in Google Scholar
Zakotnik B, Zadnik V, Žagar T, Primic-Žakelj M, Ivanuš U, Jerman T, et al. Reaching sustainable oncology care via the National Cancer Control Program (NCCP). Ann Oncol 2019; 30: v673. doi: /10.1093/annonc/mdz263.009.ZakotnikBZadnikVŽagarTPrimic-ŽakeljMIvanušUJermanTet alReaching sustainable oncology care via the National Cancer Control Program (NCCP)201930v673doi: /10.1093/annonc/mdz263.00910.1093/annonc/mdz263.009Search in Google Scholar
Zadnik V, Primic-Žakelj M, Žagar T. Cancer survival in children and adolescents in last 50 years in Slovenia. In: Grell. Grell 2017. Bruxelles: Belgian Cancer Registry; 2017.ZadnikVPrimic-ŽakeljMŽagarT2017BruxellesBelgian Cancer Registry2017Search in Google Scholar
Česen Mazič M, Bonevski A, Mikeskova M, Mihut E, Bisogno G, Jazbec J. Treatment of rhabdomyosarcoma in children and adolescent from four low health expenditures average rates countries. Radiol Oncol 2020; 54: 455-60. doi: 10.2478/raon-2020-0059.ČesenMazič MBonevskiAMikeskovaMMihutEBisognoGJazbecJTreatment of rhabdomyosarcoma in children and adolescent from four low health expenditures average rates countries2020544556010.2478/raon-2020-0059Open DOISearch in Google Scholar
De Angelis R, Sant M, Coleman MP, Francisi S, Baili P, Pierannunzio D, et al. Cancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5 - a population-based study. Lancet Oncol 2013; 15: 23-34. doi: 10.1016/S1470-2045(13)70546-1.De AngelisRSantMColemanMPFrancisiSBailiPPierannunzioDet alCancer survival in Europe 1999–2007 by country and age: results of EUROCARE-5 - a population-based study201315233410.1016/S1470-2045(13)70546-1Open DOISearch in Google Scholar